|
New Clorox disinfectant is EPA registered to kill both known types of MRSA
May 06, 2008While MRSA has been an issue in healthcare settings for years, CA-MRSA outbreaks in the community have been on the rise, with the greatest risk in community settings such as fitness clubs, in sports teams, at schools and daycare centers. In May, The Clorox Company will launch Clorox® Pro Quaternary All-Purpose Disinfectant Cleaner, a disinfectant that is EPA registered to kill germs, including Healthcare-associated and Community-associated methicillin-resistant Staphylococcus aureus (HA-MRSA and CA-MRSA).
Clorox® Pro Quaternary All-Purpose Disinfectant Cleaner is a one-step, labor-saving solution for killing both strains of MRSA as well as a variety of other illness causing germs, such as Hepatitis B and C, Avian Influenza A, HIV-1 and HIV-2, SARS-associated Coronavirus, Rotavirus, Salmonella enterica and E. coli. This hospital grade disinfectant is also a powerful cleaner with a no-rinse pH-neutral, bleach free formula.
"This product offers confidence to those professionals who want to help reduce the spread of germs in their environment, particularly those who are vulnerable to a CA-MRSA outbreak," said Jennifer Case, New Business Development Manager, Clorox Away from Home Division. "Clorox® Pro Quaternary All-Purpose Disinfectant Cleaner is EPA registered to kill both healthcare and community associated strains of MRSA, and is also a powerful all-in-one cleaner and disinfectant that gives you peace of mind that you are using the right product to disinfect surfaces and help reduce the risk of exposure."
Ketchum DC
Ketchum DC
MRSA News and Current MRSA Events RSSEuropean league-tables for antibiotic resistance revealed
Tests of antibiotic resistance in cattle have revealed stark variation across thirteen European countries. The results, published today in BioMed Central's open-access journal Acta Veterinaria Scandinavica, show that major differences were apparent in the occurrence of resistance between countries and between the different antimicrobial agents tested.
More severe bone infections, health complications in children linked to MRSA, researchers find
The emergence of methicillin-resistant Staphylococcus aureus (MRSA) as a major pathogen has led to more complications and longer hospital stays for children with acute bone infections, UT Southwestern Medical Center researchers report.
Overcrowding and understaffing in hospitals increases levels of MRSA infections
A review article authored by a University of Queensland academic has found overcrowding and understaffing in hospitals are two key factors in the transmission of MRSA (Meticillin - Resistant Staphylococcus Aureus) infections worldwide.
Less hype and more research needed into new 'superbug,' say experts
Recent tabloid hype over the "newly emerging superbug", Stenotrophomonas maltophilia, is misplaced, say experts in this week's issue of the BMJ.
Can we 'wipe out' MRSA?
Three basic principles is all it could take to reduce the incidence of MRSA in hospitals according to a new research by Cardiff University.
Potential treatments from cryptic genes
Big pharma gave up on soil bacteria as a source of antibiotics too soon, according to research published in the June issue of Microbiology. Scientists have been mining microbial genomes for new natural products that may have applications in the treatment of MRSA and cancer and have made some exciting discoveries.
UV lotion lights the way to cleaner facilities
A team of Canadian scientists using a lotion which glows under ultraviolet light have shown that up to a third of patient toilets are not properly cleaned.
Superbug genome sequenced
The genome of a newly-emerging superbug, commonly known as Steno, has just been sequenced. The results reveal an organism with a remarkable capacity for drug resistance. The research was carried out by scientists at the Wellcome Trust Sanger Institute near Cambridge and the University of Bristol.
Turning on cell-cell communication wipes out staph biofilms
University of Iowa researchers have succeeded in wiping out established biofilms of Staphylococcus aureus (staph) by hijacking one of the bacteria's own regulatory systems. Although the discovery is not ready for clinical application, the findings offer insight into a dispersal mechanism for staph biofilms and might help identify therapeutic targets.
'Healing clays' show promise for fighting deadly MRSA superbug infections, other diseases
Mud may be coming to a medicine cabinet or pharmacy near you. Scientists in Arizona report that minerals from clay could form the basis of a new generation of inexpensive, highly-effective antimicrobials for fighting MRSA infections that are moving out of health care settings and into the community.
More MRSA News Articles
| © 2008 BrightSurf.com |